ClinicalTrials.Veeva

Menu

Magnetic Resonance Spectroscopy (MRS) Validation Study in Individuals With Nonalcoholic Fatty Liver Disease (NAFLD)

The Washington University logo

The Washington University

Status

Completed

Conditions

Liver Diseases

Study type

Observational

Funder types

Other

Identifiers

NCT00940537
06-0229

Details and patient eligibility

About

The purpose of this study is to see how effective the investigators' optimized magnetic resonance spectroscopy (MRS) sequence in quantifying hepatic triglyceride content (HTGC) to enhance MRS as a diagnostic tool in non-alcohol fatty liver disease (NAFLD).

Full description

One way to gauge MRS as an effective diagnostic tool is by looking at the reproducibility of the liver fat measurements on subjects by calculating the coefficient of variation (CV). This study assesses the modified MRS sequence, using both breath holds and free breathing. The HTGC levels are measured twice in the same individuals on two independent events separated by 10 minutes. Subjects are then given a high fat, high carbohydrate meal of Pizza Hut pizza, Pepsi, and Oreo cookies. Two hours after eating the meal, the subjects return to the scanner and repeat all MRS scans.

Enrollment

14 patients

Sex

All

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Obese

Exclusion criteria

  • Diabetes
  • Pregnant

Trial design

14 participants in 2 patient groups

NAFLD
Description:
Non-diabetic, obese with diagnosed NAFLD (HTGC greater or equal to 5.5%)
Non-NAFLD
Description:
Non-diabetic, obese with no previous diagnosis of NAFLD

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems